Market Overview

Bristol-Myers Squibb Is Re-Testing Its Breakout Level

Related BMY
Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments
These Were The Most And Least Popular Stocks In September
Here's How Lilly And Merck Are Faring In The Cancer Drug Wars: Earnings Out Next Week (Seeking Alpha)

This Technical Trigger was provided by TraderMinute.

There is some interesting price action going on in Bristol-Myers Squibb Co (NYSE: BMY) that makes it a possible swing trade play. Bristol-Myers Squibb has been trending up since October and recently broke out to new highs and pulled back to its break out level.

Commonly, break out levels that are retested hold in bull markets and spring higher.

The Slo Stochastic and over bought/oversold indicator is showing a swing up indicating some bullish momentum in the stock.


The other bullish indicators on this stock is that the price action has continued to stay above the 50-day moving average. The volume is in line with the price action.

If the retest on Bristol-Myers holds, look for it to spring up to $69 to $72 over the next week or two. They key level to watch to the downside is $62.

Failure there, and it could pull back to around $62.

Options Corner: The April 65 Calls are trading for 1.33 and have open interest of 2,561, which offers a cheaper way to play the potential for upward move instead of buying the stock.

Posted-In: bristol-myers squibb Technical TradingLong Ideas Technicals Trading Ideas


Related Articles (BMY)

View Comments and Join the Discussion!